Research roundup: Recent grants and publications for Emory faculty and staff
Emory News Center
12 April 2022https://news.emory.edu/stories/2022/04/er_research_roundup_april_14-04-2022/story.html

Among others, a grant is: Low dose naltrexone to be studied for chronic neuropathic pain

Topical Steroid Withdrawal (TSW)

There is a need to raise awareness about Topical Steroid Withdrawal (TSW), a serious potential side
effect of topical steroid use. TSW is not always recognized by patients or practitioners as much is still
unknown about this consequence of using topical steroids, particularly long term.¹

What are skin conditions?

Dr Sajad Zalzala, LDN Radio Show February 2022 (LDN, low dose naltrexone)

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19

DocWire News Featured Reading
18 February 2022
https://www.docwirenews.com/abstracts/repurposing-low-dose-naltrexone-ldn-for-the-prevention-and-treatment-of-immunothrombosis-in-covid-19/